
ACADIA Pharmaceuticals Inc.
ACADNASDAQHealthcare● Active
$21.70
+$0.14(+0.65%)
Market Cap$3.7B
P/E Ratio—
52W High$28.35
52W Low$19.69
ACADIA Pharmaceuticals Inc.(ACAD)· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · ACAD · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.82B | $0.76B | $0.44B | $0.42B | $0.52B |
| Net Receivables | $0.15B | $0.10B | $0.10B | $0.06B | $0.07B |
| Inventory | $0.03B | $0.02B | $0.04B | $0.01B | $0.01B |
| Total Current Assets | $1.06B | $0.94B | $0.62B | $0.51B | $0.62B |
| PP&E Net | $0.05B | $0.05B | $0.06B | $0.06B | $0.07B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.11B | $0.12B | $0.07B | $0.00B | $0.00B |
| Total Assets | $1.56B | $1.19B | $0.75B | $0.59B | $0.70B |
| Liabilities | |||||
| Short-Term Debt | $0.01B | $0.00B | $0.01B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.02B | $0.02B | $0.01B | $0.01B |
| Total Current Liabilities | $0.28B | $0.39B | $0.25B | $0.13B | $0.10B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.34B | $0.45B | $0.32B | $0.19B | $0.16B |
| Stockholders Equity | |||||
| Retained Earnings | ($1.81B) | ($2.20B) | ($2.43B) | ($2.37B) | ($2.15B) |
| Total Stockholders Equity | $1.23B | $0.73B | $0.43B | $0.40B | $0.54B |
| Total Liab & Equity(computed) | $1.56B | $1.19B | $0.75B | $0.59B | $0.70B |
| Debt Summary | |||||
| Total Debt | $0.05B | $0.05B | $0.06B | $0.06B | $0.06B |
| Net Debt | ($0.13B) | ($0.27B) | ($0.13B) | ($0.05B) | ($0.08B) |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · B
深入了解ACADIA Pharmaceuticals Inc.
关于ACADIA Pharmaceuticals Inc.(ACAD)资产负债表
ACADIA Pharmaceuticals Inc.总资产$1.56B,现金及短期投资$0.82B,总负债$0.34B,总债务$0.05B,股东权益$1.23B。
常见问题
ACAD · 4 问ACADIA Pharmaceuticals Inc.总债务$0.05B,净债务($0.13B)。
ACAD total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10